CERo Therapeutics Holdings, Inc. CERO
$0.01
$0.004.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 81.01% | -15.28% | -775.79% | -14.86% | -121.23% |
| Total Depreciation and Amortization | 4.11% | 2.45% | -2.99% | -8.24% | -8.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -367.75% | 440.87% | 106.95% | 42.17% | 145.47% |
| Change in Net Operating Assets | 154.09% | 408.81% | -92.49% | -42.78% | -163.11% |
| Cash from Operations | 49.65% | 37.89% | -147.15% | -16.19% | -30.70% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.03% | -81.98% | 116.48% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 166.24% | 117.70% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -647.28% | 59.83% | -100.00% |
| Cash from Financing | -11.55% | -69.06% | 131.79% | -42.83% | 5.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.21% | -142.89% | -577.40% | -379.99% | -100.92% |